{
    "organizations": [],
    "uuid": "63f60684b1538c0c9550a71a0bf35c327b2e42af",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-mereo-biopharma-says-offering-159/brief-mereo-biopharma-says-offering-15-9-mln-of-ordinary-shares-including-ordinary-shares-in-form-of-adss-in-global-offering-idUSFWN1RM07Z",
    "ord_in_thread": 0,
    "title": "BRIEF-Mereo Biopharma Says Offering 15.9 Mln Of Ordinary Shares, Including Ordinary Shares In Form Of ADSS, In Global Offering",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 9 (Reuters) - Mereo BioPharma Group PLC:\n* SAYS OFFERING 15.9 MLN OF COâ€™S ORDINARY SHARES, INCLUDING ORDINARY SHARES IN FORM OF ADSS, IN GLOBAL OFFERING SEC FILING - SEC FILING\n* MEREO BIOPHARMA GROUP PLC SAYS OFFERING 2.8 MILLION ADSS THROUGH UNDERWRITERS IN THE UNITED STATES, OR THE U.S. OFFERING Source text ( bit.ly/2H82gCU ) Further company coverage:\n ",
    "published": "2018-04-09T18:34:00.000+03:00",
    "crawled": "2018-04-10T12:48:51.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "mereo",
        "biopharma",
        "group",
        "plc",
        "say",
        "offering",
        "mln",
        "co",
        "ordinary",
        "share",
        "including",
        "ordinary",
        "share",
        "form",
        "adss",
        "global",
        "offering",
        "sec",
        "filing",
        "sec",
        "filing",
        "mereo",
        "biopharma",
        "group",
        "plc",
        "say",
        "offering",
        "million",
        "adss",
        "underwriter",
        "united",
        "state",
        "offering",
        "source",
        "text",
        "company",
        "coverage"
    ]
}